Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Cited by (341)

Items 101–200 of 341

1. Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
   Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, Michael C. McGee, Yingying Wu, Gianluca Veggiani, Weishan Huang · 2024 · ImmunoHorizons
2. Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
   Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell et al. · 2021 · Microorganisms
3. Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones
   Lydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, Nimitha R. Mathew, Daniel J. Sheward, Susannah Leach, Pauline Isakson, Ilya Valerevich Smirnov, Emelie Marklund, Nicolae Miron et al. · 2022 · JCI Insight
4. Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants
   Jianbo Wu, Zhenguo Chen, Yidan Gao, Zegen Wang, Jiarong Wang, Bing‐Yu Chiang, Yunjiao Zhou, Yuru Han, Wuqiang Zhan, Minxiang Xie et al. · 2023 · Cell Reports
5. Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
   Felipe Lopes de Assis, Kenneth B. Hoehn, Xiaozhen Zhang, Lela Kardava, Connor D. Smith, Omar El Merhebi, Clarisa M. Buckner, Krittin Trihemasava, Wei Wang, Catherine A. Seamon et al. · 2023 · Cell Reports
6. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
   Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, Anna Aiello, Calogero Caruso, Giovanni Duro, Giuseppina Candore · 2021 · Frontiers in Cell and Developmental Biology
7. Memory B‐cell diversity: From early generation to tissue residency and reactivation
   Laura Reusch, Davide Angeletti · 2023 · European Journal of Immunology
8. Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
   Katharina Röltgen, Scott Dexter Boyd · 2023 · Annual Review of Pathology Mechanisms of Disease
9. An examination of school reopening strategies during the SARS-CoV-2 pandemic
   Alfonso Landeros, Xiang Ji, Kenneth L. Lange, Timothy C. Stutz, Jason Xu, Mary Elizabeth Sehl, Janet S. Sinsheimer · 2021 · PLoS ONE
10. Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
    Lei Peng, Zhenhao Fang, Paul A. Renauer, Andrew McNamara, Jonathan Joon-Young Park, Qianqian Lin, Xiaoyu Zhou, Matthew B. Dong, Biqing Zhu, Hongyu Zhao et al. · 2022 · Cell Reports
11. SARS-CoV-2 immunity and vaccine strategies in people with HIV
    Claire Mullender, Kelly da Costa, Aljawharah Alrubayyi, Sarah Lilian Pett, Dimitra Peppa · 2022 · Oxford Open Immunology
12. Sustained seropositivity up to 20.5 months after COVID-19
    Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, Rocío Rubio, Gemma Ruiz‐Olalla, Josep Vidal‐Alaball, Dídac Macià, Queralt Miró Catalina, Marta Vidal, Aïna Fuster‐Casanovas et al. · 2022 · BMC Medicine
13. Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
    Haisheng Yu, Banghui Liu, Yudi Zhang, Xijie Gao, Qian Wang, Haitao Xiang, Xiaofang Peng, Caixia Xie, Yaping Wang, Peiyu Hu et al. · 2023 · Nature Communications
14. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
    Xiaofei Wang, Ao Hu, Xiangyu Chen, Yixin Zhang, Fei Yu, Shuai Yue, Arong Li, Junsong Zhang, Zhiwei Pan, Yang Yang et al. · 2022 · Signal Transduction and Targeted Therapy
15. Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
    Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Jürgen Tuvikene, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring et al. · 2022 · Scientific Reports
16. Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
    Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, Vana I. Spoulou · 2024 · Vaccines
17. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
    Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martín Casapía, Meg Trahey, Ollivier Hyrien, Leigh H. Fisher, Maurine D. Miner et al. · 2021 · PLoS Medicine
18. Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination
    Lisa Paschold, Bianca Klee, Cornelia Gottschick, Edith Willscher, Sophie Diexer, Christoph Schultheiß, Donjetë Simnica, Daniel Sedding, Matthias Girndt, Michael Gekle et al. · 2022 · Frontiers in Immunology
19. Challenges and Issues of Anti-SARS-CoV-2 Vaccines
    Sophie Blumental, Patrice Debré · 2021 · Frontiers in Medicine
20. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
    Juanjie Tang, Gabrielle Grubbs, Youri Lee, Chang Huang, Supriya Ravichandran, David Forgacs, Hana Golding, Ted M. Ross, Surender Khurana · 2021 · EBioMedicine
21. Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
    Justyna Sieber, Margareta Mayer, Klara Schmidthaler, Sonja Kopanja, Jeremy Vann Camp, Amelie Popovitsch, Varsha Dwivedi, Jakub Hoz, Anja Schoof, Lukas Weseslindtner et al. · 2022 · Frontiers in Immunology
22. Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19
    Magdalene Joseph, Yin Wu, Richard Dannebaum, Florian Rubelt, Iva Zlatareva, Anna Lorenc, Zhipei Gracie Du, Daniel Davies, Fernanda Kyle‐Cezar, Abhishek Das et al. · 2022 · Proceedings of the National Academy of Sciences
23. COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins
    Evan A. Elko, Georgia A. Nelson, Heather Mead, Erin Kelley, Sophia T. Carvalho, Nathan Sarbo, Caroline E. Harms, Virginia Le Verche, Angelo A. Cardoso, Jennifer L. Ely et al. · 2022 · Cell Reports
24. Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology*
    Ksenia Rybkina, Julia Davis‐Porada, Donna L. Färber · 2022 · Immunological Reviews
25. Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry
    Marina A. Bondareva, Lisa Budzinski, Pawel Durek, Mario Witkowski, Stefan Angermair, Justus Ninnemann, Jakob Kreye, Philine Letz, Marta Ferreira‐Gomes, Iaroslav K. Semin et al. · 2023 · Cell Host & Microbe
26. High recallability of memory B cells requires ZFP318-dependent transcriptional regulation of mitochondrial function
    Yifeng Wang, Wen Shao, Xin Liu, Qingtai Liang, Jiaqi Lei, Wenjuan Shi, Miao Mei, Ying Li, Xu Tan, Guocan Yu et al. · 2024 · Immunity
27. Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation
    Olmedillas, Eduardo, Rajamanickam, Roshan R., Avalos, Ruben Diaz, Ana-Sosa-Batiz, Fernanda, Zyla, Dawid, Zandonatti, Michelle A., Harkins, Stephanie S., Shresta, Sujan, Hastie, Kathryn M., Saphire, Erica Ollmann · 2025 · Cell Reports
28. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients
    Xiangmin Qiu, Xiaoliang Hua, Qianyin Li, Qin Zhou, Juan Chen · 2021 · Frontiers in Immunology
29. Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
    Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Biochemical Society Transactions
30. A sensitive assay for measuring whole-blood responses to type I IFNs
    Adrian Gervais, Corentin Le Floc’h, Tom Le Voyer, Lucy Bizien, Jonathan Bohlen, Fatih Çelmeli, Fahd A. Al Qureshah, Cécile Masson, Jérémie Rosain, Marwa Chbihi et al. · 2024 · Proceedings of the National Academy of Sciences
31. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
    Stefan Slamanig, Irene González‐Domínguez, Lauren A. Chang, Nicholas Lemus, Tsoi Ying Lai, Jose Luis Martínez, Gagandeep Singh, Victoria Dolange, Adam Abdeljawad, Shreyas Kowdle et al. · 2024 · EBioMedicine
32. SARS‐CoV‐2 sculpts the immune system to induce sustained virus‐specific naïve‐like and memory B‐cell responses
    Leire de Campos‐Mata, Sonia Tejedor Vaquero, Roser Tachó‐Piñot, Janet Piñero, Emilie K. Grasset, Itziar Arrieta‐Aldea, Natalia Rodrigo Melero, Carlo Carolis, Juan Pablo Horcajada, Andrea Cerutti et al. · 2021 · Clinical & Translational Immunology
33. Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Judith Kannenberg, Henning Trawinski, Reinhard Henschler, Raymund Buhmann, Mario Hönemann, Christian Jassoy · 2022 · The Journal of Infectious Diseases
34. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
    María Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, Claudia Pastori, Claude Capron, Arielle R. Rosenberg, Nigel James Temperton et al. · 2022 · Frontiers in Immunology
35. Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
    Ksenia V. Zornikova, Alexandra A. Khmelevskaya, Savely A. Sheetikov, Dmitry Olegovych Kiryukhin, Olga V. Shcherbakova, Aleksei Titov, Ivan V. Zvyagin, Grigory Aleksandrovich Efimov · 2022 · Communications Biology
36. Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
    Laura Solforosi, Lea M. M. Costes, Jeroen T. B. M. Tolboom, Katherine McMahan, Tochi Anioke, David L. Hope, Tetyana Murdza, Michaela Sciacca, Emily Bouffard, Julia Barrett et al. · 2023 · Nature Communications
37. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
    Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Nirupama P. Varese, Irene Boo, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Menno C. van Zelm · 2023 · Journal of Clinical Immunology
38. Antiviral memory B cells exhibit enhanced innate immune response facilitated by epigenetic memory
    Xiping Zhu, Sheng Hong, Jiachen Bu, Yingping Liu, Can Liu, Runhan Li, Tiantian Zhang, Zhuqiang Zhang, Liping Li, Xuyu Zhou et al. · 2024 · Science Advances
39. Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages
    Mathieu A. F. Claireaux, George Elias, Gius Kerster, Lisan H Kuijper, Mariël C Duurland, A Paul, Judith A. Burger, Meliawati Poniman, Wouter Olijhoek, N. de Jong et al. · 2025 · Science Advances
40. Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis
    Adrian Gervais, Astrid Marchal, Soraya Boucherit, Anthony Abi Haidar, Lucy Bizien, Ahmet Sadık Yalçınkaya, Ella Sandström, Xiao‐Fei Kong, Emmanuel Jacquemin, Olivier Bernard et al. · 2025 · The Journal of Experimental Medicine
41. The Potential Role of Viral Persistence in the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
    Lorenzo Lupi, Adriana Vitiello, Cristina Parolin, Arianna Calistri, Alfredo Garzino Demo · 2024 · Pathogens
42. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern
    Zoë L. Lyski, Amanda E. Brunton, Matt Strnad, Peter E. Sullivan, Sarah A. R. Siegel, Fikadu Tafesse, Mark K. Slifka, William B. Messer · 2021 · The Journal of Infectious Diseases
43. A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
    Yang Li, Xi Wang, Xu-Rui Shen, Rong Geng, Nan Xie, Junfeng Han, Qing-Miao Zhang, Zheng‐Li Shi, Peng Zhou · 2022 · Emerging Microbes & Infections
44. Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination
    Furong Qi, Yingyin Cao, Shuye Zhang, Zheng Zhang · 2022 · Frontiers in Immunology
45. Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity
    Modi Safra, Zvi Tamari, Pazit Polak, Shachaf Shiber, Moshe Matan, Hani Karameh, Yigal Helviz, Adva Levy‐Barda, Vered Yahalom, Avi Peretz et al. · 2023 · Frontiers in Immunology
46. Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
    Annalisa Ciabattini, G Pastore, Simone Lucchesi, Giorgio Montesi, Simone Costagli, Jacopo Polvere, Fabio Fiorino, Elena Pettini, Arianna Lippi, Leonardo Ancillotti et al. · 2023 · Cells
47. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
48. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?
    Maurizio Federico · 2022 · International Journal of Molecular Sciences
49. Advances in understanding the formation and fate of B-cell memory in response to immunization or infection
    Liam C. Kealy, Kim L. Good‐Jacobson · 2021 · Oxford Open Immunology
50. Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
    Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, Alecsander P. da Silva, Leland O. Barrett, Scott McGoldrick, Yuvraj Lnu et al. · 2022 · Antibodies
51. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
    Marc-André Limoges, A Quenum, Mohammad Mobarak H Chowdhury, Fjolla Rexhepi, Mozhdeh Namvarpour, Sara Ali Akbari, Christine Rioux‐Perreault, Madhuparna Nandi, Jean‐François Lucier, Samuel Lemaire‐Paquette et al. · 2023 · Frontiers in Immunology
52. T and B cell responses in different immunization scenarios for COVID-19: a narrative review
    Eva Piano Mortari, Francesca Ferrucci, Irini Zografaki, Rita Carsetti, Luciano Pacelli · 2025 · Frontiers in Immunology
53. Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
    Shuai Yue, Zhirong Li, Yao Lin, Yang Yang, Mengqi Yuan, Zhiwei Pan, Hu Li, Leiqiong Gao, Jing Zhou, Jianfang Tang et al. · 2021 · Frontiers in Immunology
54. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
    Jewell N. Walters, Blake Schouest, Ami R. Patel, Emma L. Reuschel, Katherine Schultheis, Elizabeth M. Parzych, Igor Maricic, Ebony Nicole Gary, Mansi Purwar, Viviane M. Andrade et al. · 2022 · Vaccine
55. Landscape of infection enhancing antibodies in COVID-19 and healthy donors
    Hendra Saputra Ismanto, Zichang Xu, Dianita S. Saputri, Jan Wilamowski, Songling Li, Dendi Krisna Nugraha, Yasuhiko Horiguchi, Masato Okada, Hisashi Arase, Daron M. Standley · 2022 · Computational and Structural Biotechnology Journal
56. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses
    Sydney I. Ramirez, Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji, Scott F. Sieg, Justin Ritz, Carlee Moser, Joseph J. Eron et al. · 2022 · JCI Insight
57. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
    Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, István Bartha, Francesco Muoio, Katja Culap, Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni et al. · 2022 · iScience
58. enclone: precision clonotyping and analysis of immune receptors
    David B. Jaffe, Payam Shahi, Bruce A. Adams, Ashley M. Chrisman, Peter Finnegan, Nandhini Raman, Ariel E. Royall, FuNien Tsai, Thomas Vollbrecht, Daniel Reyes et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
59. The Role of SARS-CoV-2 Nucleocapsid Protein in Host Inflammation
    Yujia Cao, Yaju Wang, De-Gang Huang, Y. Tan · 2025 · Viruses
60. The epigenetic regulation of the germinal center response
    Shusheng Wu, Yuye Yin, Xiaoming Wang · 2022 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
61. Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study
    Adrien Mirouse, Alice Friol, Anne‐Sophie Moreau, Boris Jung, Edouard Jullien, Côme Bureau, Michel Djibré, Nicolas de Prost, Lara Zafrani, Laurent Argaud et al. · 2023 · Scientific Reports
62. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
63. Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
    Paulina Kapłonek, Chuangqi Wang, Yannic C. Bartsch, Stephanie Fischinger, Matthew J. Gorman, Kathryn A. Bowman, Jaewon Kang, Diana Dayal, Patrick Martin, Radosław P. Nowak et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
64. Decrypting the Immune Symphony for RNA Vaccines
    Brian Weidensee, Itishri Sahu · 2025 · Vaccines
65. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
    Irène A. Abela, Magdalena Schwarzmüller, Agnė Ulytė, Thomas Radtke, Sarah Roberta Haile, Priska Ammann, Alessia Raineri, Sonja Rueegg, Selina Epp, Christoph Berger et al. · 2024 · mBio
66. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
    Banghui Liu, Xuefeng Niu, Yijun Deng, Zhaoyong Zhang, Yanqun Wang, Xijie Gao, Huan Liang, Zimu Li, Qian Wang, Yuanyi Cheng et al. · 2024 · Cell Reports
67. Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
    Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, Timothée Bruel, Pierre Rosenbaum, Maxime Beretta, Jordan D. Dimitrov, Laurine Conquet, Flora Donati, Matthieu Prot et al. · 2024 · iScience
68. Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination
    Zhe Li, Anna Obraztsova, Fuwei Shang, Opeyemi Ernest Oludada, Joshua Malapit, Katrin Busch, Monique van Straaten, C. Erec Stebbins, Rajagopal Murugan, Hedda Wardemann · 2024 · Immunity
69. Preschool-age children maintain a distinct memory CD4 + T cell and memory B cell response after SARS-CoV-2 infection
    Benoît Manfroi, Bui Thi Cuc, Aurélien Sokal, Alexis Vandenberghe, Sarah Temmam, Mikaël Attia, Mohamed El Behi, Francesco Camaglia, Ngan Thu Nguyen, Jelka Pohar et al. · 2024 · Science Translational Medicine
70. SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
    Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, Julie Lamulle, Mélanie Hanoy, Stéphane Edet, Charlotte Laurent, Ludivine Lebourg, Isabelle Etienne, Mathilde Lemoine et al. · 2021 · Transplantation Direct
71. [Recurrence and surgical salvage of sinonasal squamous cell carcinoma].
    Xiaoming Li, Jun Li, Bin Di, Qi Song, Yongliang Shao, Yanqiao Wu, Chunmei Gao, Yao-dong Shang · 2013 · PubMed
72. Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection
    Xun Wang, Manzhu Zhang, Kaifeng Wei, Chen Li, Jinghui Yang, Shujun Jiang, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui et al. · 2024 · Vaccines
73. Clonotype-enriched somatic hypermutations drive affinity maturation of a public human antibody targeting an occluded sarbecovirus epitope
    Vishal N. Rao, Iden A. Sapse, Hallie Cohn, Duck-Kyun Yoo, Pei Tong, Jordan J. Clark, Bailey Bozarth, Yuexing Chen, Komal Srivastava, Gagandeep Singh et al. · 2025 · Cell Reports
74. Functional heterogeneity in the memory B-cell response
    Brittany Henry, Brian J. Laidlaw · 2023 · Current Opinion in Immunology
75. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients
    Daniela Loconsole, Emma Diletta Stea, Anna Sallustio, Giulia Fontò, Virginia Pronzo, Simona Simone, Francesca Centrone, Marisa Accogli, Loreto Gesualdo, Maria Chironna · 2021 · Vaccines
76. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
    Li Min, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, Zhenchuan Wu, Xiangyin Kong, Yufei Zhu, Xianchao Zhou et al. · 2022 · Journal of Allergy and Clinical Immunology
77. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Guidenn Sulbarán, Pauline Maisonnasse, Axelle Amen, Grégory Effantin, Delphine Guilligay, Nathalie Dereuddre‐Bosquet, Judith A. Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson et al. · 2022 · Cell Reports Medicine
78. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas
    Abdouramane Traoré, Merepen A. Guindo, Drissa S Konate, Bourama Traoré, Seidina A. S. Diakité, Salimata Kanté, Assitan Dembélé, Abdourhamane Cissé, Nathan C. Incandela, Mamoudou Kodio et al. · 2022 · Frontiers in Immunology
79. High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection
    Antonio Facciuolo, Erin Scruten, Sean Lipsit, Amanda L. S. Lang, Zoë Parker Cates, Jocelyne M. Lew, Darryl Falzarano, Volker Gerdts, ANTHONY J. KUSALIK, Scott Napper · 2022 · Scientific Reports
80. Ph-Positive B-Cell Acute Lymphoblastic Leukemia Occurring after Receipt of Bivalent SARS-CoV-2 mRNA Vaccine Booster: A Case Report
    Shy‐Yau Ang, Yi‐Fang Huang, Chung‐Ta Chang · 2023 · Medicina
81. Infant Antibody Repertoires during the First Two Years of Influenza Vaccination
    Masayuki Kuraoka, Nicholas C. Curtis, Akiko Watanabe, Hidetaka Tanno, Seungmin Shin, Kevin Ye, Elizabeth A. MacDonald, Olivia Lavidor, Susan Kong, Tarra A. Von Holle et al. · 2022 · mBio
82. Transdermal delivery of Fluoropolymer-Modified microneedle vaccines against rabies elicits potent humoral immunity
    Jiamin Deng, Zongmei Wang, Zhipeng Zhou, Wentao Yu, Xun Li, Zhiyong Song, Heyou Han, Ling Zhao · 2023 · Chemical Engineering Journal
83. Monitoring Immune Responses to Vaccination: A Focus on Single-Cell Analysis and Associated Challenges
    L. C. Montgomery, Anis Larbi · 2025 · Vaccines
84. Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
    Jerry C H Tam, Abbie C. Sibayan, Jeffrey Seow, Carl Graham, Ashwini Kurshan, Blair Merrick, Richard James Stanton, Katie J. Doores · 2025 · Cell Reports
85. Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
    Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park, Sandhya Bangaru, Lei Li, Chloe A. Troxell, Peter Halfmann, Steven A. Erickson, Nicholas Catanzaro, Meng Yuan et al. · 2025 · The Journal of Experimental Medicine
86. Humoral and cellular immunity against diverse SARS-CoV-2 variants
    Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
87. Deciphering the antigen specificities of antibodies by clustering their complementarity determining region sequences
    Dianita S. Saputri, Hendra Saputra Ismanto, Dendi Krisna Nugraha, Zichang Xu, Yasuhiko Horiguchi, Shuhei Sakakibara, Daron M. Standley · 2023 · mSystems
88. Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection
    Dean C. Bottino, Greg Hather, Lin Yuan, Madison Stoddard, Lin White, Arijit Chakravarty · 2021 · Antibody Therapeutics
89. Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
    Cory A. Perugino, Hang Liu, Jared E. Feldman, Blake Marie Hauser, Catherine Jacob-Dolan, Anusha Nathan, Zezhou Zhou, Clarety Kaseke, Rhoda Tano-Menka, Matthew A. Getz et al. · 2022 · medRxiv
90. Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal
    Sabela Lens, Alice R. Burton, Jessica E. Davies, Maëlle Locatelli, Mireia García‐López, Anna Pocurull, Anna Jeffery-Smith, Nikolai Y. Novikov, Simon P. Fletcher, Xavier Forns et al. · 2025 · Gut
91. Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants
    Kiyomi Shitaoka, Akifumi Higashiura, Yohei Kawano, Akima Yamamoto, Yoko Mizoguchi, Takao Hashiguchi, Norihisa Nishimichi, Shiyu Huang, Ayano Ito, Shun Ohki et al. · 2023 · Communications Biology
92. Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination
    Wan‐Ting Huang, Shao‐Wen Weng, Hong‐Tai Tzeng, Feng-Chun Yen, Yu-Shao Chiang, Huey‐Ling You · 2022 · Vaccines
93. Biological and Immune Responses to Current Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production
    Maurizio Federico · 2022 · Journal of Immunology Research
94. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
    Javier García‐Pérez, María González-Pérez, María Castillo de la Osa, Alberto Manuel Borobia, Luis Antonio Castaño, M.J. Bertran, Magda Campins, Antonio Portolés, David Lora, Mercedes Bermejo et al. · 2022 · EClinicalMedicine
95. Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic
    Luis Manuel Molinos-Albert, Rocío Rubio, Carla Martín-Pérez, Edwards Pradenas, Cèlia Torres, Alfons Jiménez, Mar Canyelles, Marta Vidal, Diana Barrios, Sílvia Marfil et al. · 2025 · Cell Reports
96. Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection
    Lela Kardava, James Lim, Clarisa M. Buckner, Felipe Lopes de Assis, Xiaozhen Zhang, Wei J. Wang, Mattie L. S. Melnyk, Omar El Merhebi, Krittin Trihemasava, I‐Ting Teng et al. · 2025 · Cell Reports
97. High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
    Money Gupta, Harikrishnan Balachandran, Raymond H. Y. Louie, Hui Li, David Agapiou, Elizabeth Keoshkerian, Daniel Christ, William D. Rawlinson, Michael Mina, Jeffrey John Post et al. · 2022 · Immunology and Cell Biology
98. Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
    Anna Lundgren, Susannah Leach, Hannes Axelsson, Pauline Isakson, Kristina Nyström, Lydia Scharf, Bengt A. Andersson, Nicolae Miron, Emelie Marklund, Lars‐Magnus Andersson et al. · 2023 · Clinical & Experimental Immunology
99. Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
    Mikako Ueno, Naoko Iwata‐Yoshikawa, Akihiro Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yu Yaoita et al. · 2022 · Antiviral Research
100. Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19
     Maggie L. Bartlett, San Suwanmanee, Nadine Peart Akindele, Shristi Ghimire, Andy Kwan Pui Chan, Chenxu Guo, Stephen J. Gould, Andrea L. Cox, Diane E. Griffin · 2022 · Viral Immunology